Related Experiment Video

Updated: May 7, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma

Jolieke G van Oosterwijk1, Jakob K Anninga, Hans Gelderblom

  • 1Department of Pathology, Leiden University Medical Center, PO Box 9600, L1-Q, Leiden RC 2300, The Netherlands.

Hematology/Oncology Clinics of North America
|October 8, 2013
PubMed

Insights

This review covers osteosarcoma and chondrosarcoma, the most common bone cancers. It details their features, new developments, and potential clinical treatments.

Area of Science:

  • Orthopedic Oncology
  • Skeletal Tumors
  • Cancer Biology

Background:

  • Osteosarcoma and chondrosarcoma are the most prevalent primary malignant bone tumors.
  • Understanding their clinicopathologic features is crucial for effective management.
  • Advances in research are identifying new therapeutic targets.

Purpose of the Study:

  • To review the clinicopathologic characteristics of osteosarcoma and chondrosarcoma.
  • To discuss recent preclinical developments in understanding these bone cancers.
  • To identify and evaluate emerging therapeutic targets for clinical validation.

Main Methods:

  • Literature review of clinicopathologic features.
  • Analysis of preclinical research findings.
  • Identification and assessment of potential therapeutic targets.

Main Results:

  • Detailed description of the distinct clinicopathologic profiles of osteosarcoma and chondrosarcoma.
  • Summary of promising preclinical advancements and molecular insights.
  • Compilation of validated and potential clinical targets for these bone malignancies.

Conclusions:

  • Osteosarcoma and chondrosarcoma require continued research into their unique features.
  • Preclinical developments offer a pipeline for novel therapeutic strategies.
  • Targeted therapies hold promise for improving outcomes in patients with these bone tumors.
Keywords:
Bone tumorChemotherapyChondrosarcomaHypoxiaOsteosarcomaSarcomaTargeted therapy

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...